Ausgabe 3/2013
Inhalt (17 Artikel)
Personalized medicine for breast cancer: dream or reality?
- review
Lina Pugliano, Dimitrios Zardavas, Martine Piccart
Aggressive lymphoma at ASH 2012: new standards and new perspectives
- short review
Thomas Nösslinger, Thomas Nösslinger
ASH 2012 update chronic lymphocytic leukemia—the best is yet to come
- short review
Lukas Weiss, Thomas Melchardt, Richard Greil, Georg Hopfinger
Philadelphia-negative myeloproliferative neoplasms at the 2012 ASH meeting: a personal summary
- short review
Stefan Schmidt
Acute myeloid leukemia: highlights from the 54th ASH meeting held in Atlanta, Georgia
- short review
Elisabeth Koller
Georgia on my mind: multiple myeloma highlights at ASH 2012
- short review
Wolfgang Willenbacher, Ella Willenbacher
What’s new in Hodgkin’s lymphoma: ASH 2012 and more
- short review
Thomas Melchardt, Lukas Weiss, Richard Greil, Alexander Egle
Cancer-associated venous thromboembolism: risk assessment, prevention, and treatment
- short review
Clemens Feistritzer
Biosimilars versus generics: scientific basics and clinical implications
- short review
Harald H. Sitte, Michael Freissmuth
Controversial issues in the therapy of oesophageal carcinoma
- short review
Thomas Ruhstaller, Michael Stahl
Radiofrequency ablation in gastrointestinal cancer: obstacles and goals
- short review
Gerlig Widmann, Reto Bale
